Benjamin Halladay
Chief Financial Officer · 5 filings · Latest: Oct 5, 2026
ACHIEVE LIFE SCIENCES, INC.
Esperion Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ESPR | Benjamin Halladay | Chief Financial Officer | Jun 17, 2026 | Sale | $3.15 | 10,773 | $34.0K | 702,829 | |
ESPR | Halladay Benjamin | — | Jun 17, 2026 | Proposed Sale | $3.15 | 10,773 | $34.0K | — | |
ESPR | Benjamin Halladay | Chief Financial Officer | Mar 17, 2026 | Sale | $2.71 | 6,424 | $17.4K | 713,602 | |
ESPR | Halladay Benjamin | — | Mar 17, 2026 | Proposed Sale | $2.70 | 6,424 | $17.4K | — | |
ESPR | Halladay Benjamin | — | Dec 17, 2025 | Proposed Sale | $3.67 | 7,337 | $26.9K | — | |
ESPR | Halladay Benjamin | — | Sep 17, 2025 | Proposed Sale | $2.81 | 7,046 | $19.8K | — | |
ESPR | Halladay Benjamin | — | Jul 17, 2025 | Proposed Sale | $1.12 | 11 | $12 | — | |
ESPR | Halladay Benjamin | — | Jun 17, 2025 | Proposed Sale | $1.15 | 7,229 | $8.3K | — | |
ESPR | Halladay Benjamin | — | Apr 17, 2025 | Proposed Sale | $0.9638 | 8 | $8 | — | |
ESPR | Halladay Benjamin | — | Mar 18, 2025 | Proposed Sale | $1.48 | 3,535 | $5.2K | — | |
ESPR | Halladay Benjamin | — | Feb 19, 2025 | Proposed Sale | $1.86 | 11 | $20 | — | |
ESPR | Halladay Benjamin | — | Jan 17, 2025 | Proposed Sale | $2.25 | 9 | $20 | — | |
ESPR | Halladay Benjamin | — | Dec 17, 2024 | Proposed Sale | $2.42 | 3,245 | $7.9K | — |